Method: ICP-MS (Inductively Coupled Plasma Mass Spectrometry) with creatinine normalization by Jaffe Reaction (CLIA 14D0646470); not cleared or approved by the FDA. Results in µg/g creatinine; reference intervals based on NHANES population data under non-provoked conditions. Not a stand-alone diagnosis; should be interpreted in clinical context.
A derived biomarker is a value that is calculated from other directly measured biomarkers rather than being measured directly in the lab.
Key benefits of Beryllium (Be) testing
- Beryllium occupational and industrial exposure tracking
- rare but highly toxic metal monitoring
What is Beryllium (Be)?
Beryllium is a rare, lightweight metal used in aerospace, nuclear, and electronics industries. Non-occupational exposure is uncommon. Urinary beryllium is primarily a marker of occupational or industrial exposure. Measured via ICP-MS.
Why is Beryllium (Be) important?
Beryllium is classified as a known human carcinogen (per IARC and NIOSH). Sensitized individuals may develop chronic beryllium disease upon re-exposure - a condition that warrants occupational medical evaluation. Even low-level occupational beryllium exposure warrants monitoring. Detection in non-occupationally exposed individuals is rare.
What insights will I get?
Your beryllium level may indicate occupational or industrial exposure. Detectable beryllium in non-industrial contexts may reflect environmental contamination. Discuss any elevated finding with your care team.





.avif)
.avif)

